Table 1.
Main clinical, ultrasonographic, and laboratory data for patients with NAFLD and control subjects
| Group | Mean | SD | 95% CI | Significance (two-tailed) | |
|---|---|---|---|---|---|
| Age | Case | 38.71 | 4.952 | −1.170 | 0.665 |
| Control | 38.38 | 4.084 | −1.134 | 0.657 | |
| ALT | Case | 32.43 | 16.914 | 1.445 | 0.010 |
| Control | 26.37 | 9.375 | 1.745 | 0.006 | |
| AST | Case | 20.50 | 8.076 | −0.877 | 0.222 |
| Control | 19.06 | 5.567 | −0.774 | 0.201 | |
| FBS | Case | 91.81 | 8.602 | −1.277 | 0.297 |
| Control | 90.37 | 7.948 | −1.250 | 0.292 | |
| TG | Case | 104.67 | 20.884 | −5.960 | 0.735 |
| Control | 103.43 | 23.457 | −6.076 | 0.739 | |
| Cholesterol | Case | 137.93 | 34.811 | −18.723 | 0.114 |
| Control | 146.28 | 27.348 | −18.412 | 0.103 | |
| HDL | Case | 49.06 | 6.337 | −5.428 | 0.002 |
| Control | 52.40 | 6.466 | −5.434 | 0.002 | |
| CIMT | Case | 0.640 | 0.0958 | 0.0581 | 0.000 |
| Control | 0.554 | 0.0752 | 0.0589 | 0.000 | |
| Increased in diameter | Case | 0.2298 | 0.11384 | −0.38290 | 0.000 |
| Control | 0.5723 | 0.13522 | −0.38385 | 0.000 | |
| BMI | Case | 24.4545 | 1.27104 | −0.12928 | 0.172 |
| Control | 24.1614 | 1.32235 | −0.13174 | 0.175 | |
| Brachial artery diameter prior to ischemia | Case | 3.924 | 0.1911 | −0.0023 | 0.058 |
| Control | 3.858 | 0.2263 | −0.0039 | 0.064 | |
| Brachial artery diameter after ischemia | Case | 4.154 | 0.1997 | −0.3464 | 0.000 |
| Control | 4.431 | 0.2270 | −0.3476 | 0.000 |
Abbreviations: CI, confidence interval; FBS, fasting blood glucose; TG, triglycerides; HDL, high-density lipoproteins; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CIMT, carotid intima media thickness; BMI, body mass index; SD, standard deviation.